Today's Analysis on Bristol-Myers Squibb, Eli Lilly & Co., Endo Pharma, and Allergan PR Newswire LONDON, March 28, 2013 LONDON, March 28, 2013 /PRNewswire/ -- Markets failed to sustain its Tuesday gains and closed flat. Ongoing Cyprus crisis had negative impact on the stocks as concerns about bank deposits grew further. However, decline in prices was taken as a buying opportunity by the markets and the indices closed flat. Our research team took a look at Healthcare sector including major companies like Bristol Myers Squibb Co. (NYSE: BMY), Eli Lilly & Co. (NYSE: LLY), Endo Health Solutions Inc. (NASDAQ: ENDP) and Allergan Inc. (NYSE: AGN). StockCall professionals have completed their technical analysis on BMY, LLY, ENDP, and AGN and these free reports are accessible by registering at http://www.stockcall.com/research Bristol Myers Squibb Co.'s stock closed at $40.78, 0.25 percent up. The stock traded in the range of $40.36 and $40.83 during Wednesday's session, which is also its 52 weeks high price point. It is currently trading above its 20-day moving average price of $40.77. The company has gained 27.84 percent so far this year. Its Price/Earnings ratio is 35.46, which makes it a slightly expensive stock to own. It is in a bullish phase and its first resistance level is at $40.95. On the downside, its first support is at $40.23. Upon breaching this level, its second support level is at $39.85. Sign up for the free technical research on BMY at http://www.StockCall.com/BMY032813.pdf With a mild gain in its previous trading session, Eli Lilly & Co. is still up 15.99 percent for the year. It has gained 41.83 percent in the past 52 weeks. The stock closed 0.14 percent higher at $56.37 on volume of 3.42 shares yesterday. Its average trading volume stands at 5.27 million shares. Eli Lilly & Co.'s shares currently face resistance at around $56.55. Upon breaching this level, it may go up to $56.85 level. The stock has support at around $56.04. It is trading above its 20-day and 50-day moving average price of $55.22 and $54.32, which is a bullish signal. Be sure to read our latest technical research on LLY by registering at http://www.StockCall.com/LLY032813.pdf Endo Health Solutions Inc. traded in the range of $30.39 and $30.84 during Wednesday's trading session. It opened at $30.55 and closed at $30.74, up 0.10 percent. The stock is currently in a bullish mode and has its first resistance level at $30.85. Upon breaching this level, Endo Health Solutions may go as high as $30.94. It traded 978,053 shares and is trading above its 20-day moving average price of $30.68, confirming its bullish mode. Its first support level is at $30.55. So far in year 2013, the stock is up 20.08 percent. Sign up and read the complimentary report on ENDP at http://www.StockCall.com/ENDP032813.pdf In-line with the bearish sentiments shown by broad market indices, Allergan Inc.'s stock finished 0.12 percent lower at $111.63, with volume down from daily average of 1.30 million to 675,338 shares. The company's stock is up so far in 2013 with its year-to-date gain at 23.85 percent. However, the stock currently shows a neutral trend which is further confirmed by its MACD chart. The company has its first support level at $111.05. In the coming trading sessions, the stock is likely to go as high as $112.25. The free report on AGN can be downloaded by signing up now at http://www.StockCall.com/AGN032813.pdf About StockCall.com StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at http://www.stockcall.com SOURCE StockCall.com Contact: Contact Person:William T. Knight, Email: email@example.com, Contact Number: +1(646)396-9857 (9:00 am EST - 01:30 pm EST)
Today's Analysis on Bristol-Myers Squibb, Eli Lilly & Co., Endo Pharma, and Allergan
Press spacebar to pause and continue. Press esc to stop.